• Anti-IgA Antibody
  • D-Dimer
  • Fragile X, FMR1 Gene Mutation Analysis
  • Immunoperoxidase Stain
  • Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • Brain-derived Neurotrophic Factor (BDNF) Genotyping
  • PTPN11 Gene Mutation Analysis for Noonan Syndrome
  • Breast Cancer Gene Expression Profile (MammaPrint)
  • Giardia Antigen, Stool
  • Pyruvate, Spinal Fluid
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 27- 29
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 27- 29
Medical Test

Methodology
Access to Cancer Antigen (CA) 27- 29 is restricted.
Loading...